<ul data-eligibleForWebStory="false"><li>Alphabet's drug discovery arm, Isomorphic Labs, plans to start human testing of AI-designed drugs.</li><li>Isomorphic Labs, grown out of Google DeepMind's AlphaFold, utilizes AI to speed up and enhance drug discovery.</li><li>The company has secured significant funding, signed research deals, and aims to improve drug development efficiency and success rates using AI.</li><li>Isomorphic Labs envisions a future where AI can quickly design drugs for specific diseases, revolutionizing the pharmaceutical industry.</li></ul>

Google DeepMind exec says AI-designed drugs are nearing human trials

Discover more